Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials.
Saved in:
| Title: | Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials. |
|---|---|
| Authors: | Viviani S; Division of Onco-Hematology, IEO, European Institute of Oncology, IRCCS, Milano, Italy. simonetta.viviani@ieo.it.; Department of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. simonetta.viviani@ieo.it., Pavoni C; Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy., Barrington SF; King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK., Guerra L; School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.; Department of Nuclear Medicine, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Schöder H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Johnson P; Cancer Research UK Centre, University of Southampton, Southampton, UK., Kirkwood AA; Cancer Research UK and University College London Cancer Trials Centre, London, UK., Stephens DM; Division of Hematology, University of North Carolina, Chapel Hill, NC, USA., Friedberg JW; Division of Hematology/Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Chauvie S; Division of Medical Physics, Santa Croce e Carle Hospital, Cuneo, Italy., Knopp MV; Department of Radiology, Wright Center of Innovation in Biomedical Imaging, The Ohio, State University Wexner Medical Center, Columbus, OH, USA., Luminari S; Hematology Division, Azienda USL IRCCS of Reggio Emilia, Reggio Emilia, Italy., Molin D; Department of Immunology Genetics, and Pathology Cancer Immunotherapy Uppsala, University Uppsala Akademiska Hospital, Uppsala, Sweden., Corradini P; Department of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Gallamini A; Research and Innovation Department, A. Lacassagne Cancer Center, Nice, France., Rambaldi A; Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy.; Department of Oncology and Hematology, University of Milano, Milano, Italy., Tarella C; Division of Onco-Hematology, IEO, European Institute of Oncology, IRCCS, Milano, Italy. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Oct 16; Vol. 15 (1), pp. 165. Date of Electronic Publication: 2025 Oct 16. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-025-01364-z |
